article thumbnail

FTC’s Proposed Non-Compete Rule: A Step in the Right Direction for Health Care and Biotechnology

Bill Of Health

By Aparajita Lath In January, the Federal Trade Commission (FTC) released a new draft rule that would categorically ban non-compete clauses — contractual terms between an employer and an employee that prevent subsequent employment at a competing firm — across the country.

article thumbnail

ChristianaCare Spins Out New Gene Editing Company, CorriXR Therapeutics

HIT Consultant

What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Conclusion to the Symposium: From Principles to Practice: Human Rights and Public Health Emergencies

Bill Of Health

The Principles affirm States’ obligations to cooperate towards measures that prepare for, prevent and respond to public health emergencies. She concludes that “strong, well-coordinated and resilient public health care services play a vital role in preventing and responding to public health crises.” Ahmed et al.

article thumbnail

Protecting the Consumer at the Heart of DTC Precision Medicine

Bill Of Health

The innovation-security tradeoff is a familiar trope in biotechnology, but the main character of the direct-to-consumer tissue-based service story is less so. The FTC can also make rules to help prevent data breaches before they occur, and is in fact moving towards formal rulemaking in consumer privacy. Turning to the FTC?

article thumbnail

Trying and Sentencing Youth As Adults: Key Takeaways from Recent Petrie-Flom Center Event

Bill Of Health

Panelists discussed these topics during a recent webinar hosted by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. She discussed additional relevant neuroscience concepts, such as structural changes in gray matter and cortical thickness, and changes in personality and self-regulation.

article thumbnail

Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype

Bill Of Health

Dr. Devenot is also an affiliated researcher with Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Neşe Devenot, PhD is a Senior Lecturer in the University Writing Program at the Johns Hopkins University.

article thumbnail

Psychedelic Policy on the Federal Level: Key Takeaways from a Petrie-Flom Center Panel

Bill Of Health

To navigate the myriad interests and stakes involved in creating federal psychedelic policy, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School convened a virtual panel discussion with three leading psychedelic policy advocates. By James R. A full video of the event is available below.